Thank you.
We have estimates of 60,000 job losses, so we're trying to determine where jobs will be created through the deal as well.
Mr. Colford, you brought up drug costs and the patent extensions. This is one of the most deeply concerning pieces of the Trans-Pacific Partnership to most Canadians. I wonder if you could give us a perspective from your membership, as well as from people in general in New Brunswick how they feel about the cost of drugs being increased through the Trans-Pacific Partnership. You also mentioned pharmacare. How would they feel about the inability of us to create a pharmacare program because we could potentially be sued for doing so?